GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 239 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q4 2019. The put-call ratio across all filers is 0.30 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $16,982,000 | +87.9% | 350,000 | +75.0% | 0.68% | +254.7% |
| Q2 2018 | $9,040,000 | -6.4% | 200,000 | 0.0% | 0.19% | +58.7% |
| Q1 2018 | $9,660,000 | -29.9% | 200,000 | -42.9% | 0.12% | -41.8% |
| Q4 2017 | $13,773,000 | -19.4% | 350,000 | -36.4% | 0.21% | -29.3% |
| Q3 2017 | $17,078,000 | +78.4% | 550,000 | +57.1% | 0.29% | +76.0% |
| Q2 2017 | $9,573,000 | +48.4% | 350,000 | +100.0% | 0.17% | +16.8% |
| Q1 2017 | $6,449,000 | +81.4% | 175,000 | -28.9% | 0.14% | +81.0% |
| Q4 2016 | $3,555,000 | +54.2% | 246,054 | +146.1% | 0.08% | +71.7% |
| Q3 2016 | $2,305,000 | +11.1% | 100,000 | -20.0% | 0.05% | +7.0% |
| Q2 2016 | $2,074,000 | – | 125,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alerce Investment Management, L.P. | 356,270 | $24,262,000 | 23.36% |
| Twin Securities, Inc. | 376,669 | $25,651,000 | 11.94% |
| Paradigm Biocapital Advisors LP | 1,175,879 | $80,077,000 | 10.68% |
| Chicago Capital Management, LLC | 246,246 | $16,769,000 | 9.12% |
| HARVEST MANAGEMENT LLC | 141,500 | $9,636,000 | 7.78% |
| Fernwood Investment Management, LLC | 174,724 | $11,899,000 | 5.02% |
| ArchPoint Investors | 168,725 | $11,490,000 | 4.69% |
| HAVENS ADVISORS LLC | 46,000 | $3,133,000 | 4.69% |
| Perceptive Advisors | 2,322,247 | $158,145,000 | 4.59% |
| Crabel Capital Management, LLC | 112,680 | $7,674,000 | 4.48% |